Procter & Gamble, Mason Business Center, Mason, OH, USA.
Amnis Flow Cytometry, Luminex Corporation, Austin, TX, USA.
Mutat Res Genet Toxicol Environ Mutagen. 2021 May;865:503314. doi: 10.1016/j.mrgentox.2021.503314. Epub 2021 Jan 20.
The reconstructed skin micronucleus (RSMN) assay was developed in 2006, as an in vitro alternative for genotoxicity evaluation of dermally applied chemicals or products. In the years since, significant progress has been made in the optimization of the assay, including publication of a standard protocol and extensive validation. However, the diverse morphology of skin cells makes cell preparation and scoring of micronuclei (MN) tedious and subjective, thus requiring a high level of technical expertise for evaluation. This ultimately has a negative impact on throughput and the assay would benefit by the development of an automated method which could reduce scoring subjectivity while also improving the robustness of the assay by increasing the number of cells that can be scored. Imaging flow cytometry (IFC) with the ImageStream Mk II can capture high-resolution transmission and fluorescent imagery of cells in suspension. This proof-of-principle study describes protocol modifications that enable such automated measurement in 3D skin cells following exposure to mitomycin C and colchicine. IFC was then used for automated image capture and the Amnis® Artificial Intelligence (AAI) software permitted identification of binucleated (BN) cells with 91% precision. On average, three times as many BN cells from control samples were evaluated using IFC compared to the standard manual analysis. When IFC MNBN cells were visually scored from within the BN cell images, their frequency compared well with manual slide scoring, showing that IFC technology can be applied to the RSMN assay. This method enables faster time to result than microscope-based scoring and the initial studies presented here demonstrate its capability for the detection of statistically significant increases in MNBN frequencies. This work therefore demonstrates the feasibility of combining IFC and AAI to automate scoring for the RSMN assay and to improve its throughput and statistical robustness.
2006 年,人们开发了重建皮肤微核(RSMN)测定法,作为评估经皮应用的化学品或产品遗传毒性的体外替代方法。自那时以来,该测定法的优化取得了重大进展,包括发布了标准方案和广泛的验证。然而,皮肤细胞的形态多样使得微核(MN)的细胞制备和评分繁琐且主观,因此需要高水平的技术专业知识进行评估。这最终对通量产生了负面影响,并且通过开发一种自动化方法可以减少评分的主观性,同时通过增加可以评分的细胞数量来提高测定法的稳健性,该测定法将从中受益。ImageStream Mk II 成像流式细胞术(IFC)可以捕获悬浮细胞的高分辨率透射和荧光图像。这项原理验证研究描述了可以对丝裂霉素 C 和秋水仙素处理后的 3D 皮肤细胞进行这种自动测量的方案修改。然后,IFC 用于自动图像捕获,Amnis®人工智能(AAI)软件允许以 91%的精度识别双核(BN)细胞。与标准手动分析相比,使用 IFC 平均可以评估来自对照样品的三倍数量的 BN 细胞。当从 BN 细胞图像内对 IFC MNBN 细胞进行目视评分时,它们的频率与手动幻灯片评分相当,表明 IFC 技术可应用于 RSMN 测定法。与基于显微镜的评分相比,这种方法可以更快地获得结果,并且本文介绍的初步研究表明,它具有检测 MNBN 频率统计学上显著增加的能力。因此,这项工作证明了结合 IFC 和 AAI 以自动评分 RSMN 测定法并提高其通量和统计稳健性的可行性。